CompletedNot Applicable

Combined Amniotic Membrane and Platelet Rich Plasma Clot for Management of Central Corneal Perforation

Egypt10 participantsStarted 2018-04-15

Plain-language summary

Use of amniotic membrane(AMT) and platelet rich plasma (PRP) clot for closure of central corneal perforation

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * central corneal perforation Exclusion Criteria: * active infection * posterior segment pathology * non seeing eye

Closure of the corneal wound

Timeframe: 3 months

NCT IDNCT03500796

SponsorMinia University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-12-31